tiprankstipranks
Siemens Healthineers AG (DE:SHL)
XETRA:SHL
Germany Market

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

110 Followers
See the Price Targets and Ratings of:

SHL Analyst Ratings

Strong Buy
12Ratings
Strong Buy
9 Buy
3 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Siemens
Healthineers AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHL Stock 12 Month Forecast

Average Price Target

€53.42
▲(48.44% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is €53.42 with a high forecast of €61.16 and a low forecast of €41.91. The average price target represents a 48.44% change from the last price of €35.99.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"€35","62":"€62","41.75":"€41.8","48.5":"€48.5","55.25":"€55.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":61.16286502411938,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€61.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":53.4223907979,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€53.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":41.90604128895618,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€41.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,41.75,48.5,55.25,62],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.39,38.295605001855336,40.20121000371067,42.10681500556601,44.01242000742135,45.91802500927668,47.82363001113202,49.72923501298736,51.634840014842695,53.54044501669803,55.446050018553365,57.3516550204087,59.257260022264035,{"y":61.16286502411938,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.39,37.70018390753077,39.01036781506154,40.320551722592306,41.63073563012308,42.94091953765385,44.25110344518462,45.56128735271538,46.87147126024615,48.181655167776924,49.491839075307695,50.802022982838466,52.11220689036924,{"y":53.4223907979,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,36.39,36.81431086838125,37.23862173676249,37.66293260514374,38.08724347352498,38.511554341906226,38.93586521028747,39.360176078668715,39.784486947049956,40.208797815431204,40.633108683812445,41.05741955219369,41.481730420574934,{"y":41.90604128895618,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":48.943,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.267,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.715,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.818,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.58,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.213,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.429,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.59,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.865,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.346,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.37,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.39,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€61.16Average Price Target€53.42Lowest Price Target€41.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on DE:SHL
Goldman Sachs
Goldman Sachs
€52€45
Hold
25.03%
Upside
Reiterated
04/07/26
Siemens Healthineers AG (SEMHF) Gets a Hold from Goldman Sachs
UBS
Hold
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Travere Therapeutics (NASDAQ: TVTX)
RBC Capital
€55
Buy
52.82%
Upside
Reiterated
03/31/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Deutsche Bank  Analyst forecast on DE:SHL
Deutsche Bank
Deutsche Bank
€46€42
Hold
16.70%
Upside
Reiterated
03/27/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (NASDAQ: MGTX), Hims & Hers Health (NYSE: HIMS) and Siemens Healthineers AG (Other OTC: SEMHF)
Barclays
€59€55
Buy
52.82%
Upside
Reiterated
03/25/26
Barclays Remains a Buy on Siemens Healthineers AG (SEMHF)
Jefferies Analyst forecast on DE:SHL
Jefferies
Jefferies
€60
Buy
66.71%
Upside
Reiterated
03/24/26
Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), Viatris (VTRS)
Bernstein
€52.15
Buy
44.90%
Upside
Reiterated
03/16/26
Analysts Offer Insights on Healthcare Companies: Cipher Pharmaceuticals (Other OTC: CPHRF) and Siemens Healthineers AG (Other OTC: SEMHF)
J.P. Morgan Analyst forecast on DE:SHL
J.P. Morgan
J.P. Morgan
€61.3
Buy
70.33%
Upside
Reiterated
03/13/26
J.P. Morgan Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
DZ BANK AG Analyst forecast on DE:SHL
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
03/09/26
DZ BANK AG Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
DBS
€52
Buy
44.48%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
Citi
€60€59
Buy
63.93%
Upside
Reiterated
02/10/26
Siemens Healthineers price target lowered to EUR 59 from EUR 60 at CitiSiemens Healthineers price target lowered to EUR 59 from EUR 60 at Citi
Berenberg Bank Analyst forecast on DE:SHL
Berenberg Bank
Berenberg Bank
€54
Buy
50.04%
Upside
Reiterated
02/05/26
Berenberg Bank Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
Morgan Stanley Analyst forecast on DE:SHL
Morgan Stanley
Morgan Stanley
€48€45
Hold
25.03%
Upside
Reiterated
12/15/25
Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan StanleySiemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley
Exane BNP Paribas Analyst forecast on DE:SHL
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
€48
Hold
33.37%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Kepler Capital  Analyst forecast on DE:SHL
Kepler Capital
Kepler Capital
€59
Buy
63.93%
Upside
Reiterated
11/13/25
Kepler Capital Remains a Buy on Siemens Healthineers AG (SEMHF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on DE:SHL
Goldman Sachs
Goldman Sachs
€52€45
Hold
25.03%
Upside
Reiterated
04/07/26
Siemens Healthineers AG (SEMHF) Gets a Hold from Goldman Sachs
UBS
Hold
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Travere Therapeutics (NASDAQ: TVTX)
RBC Capital
€55
Buy
52.82%
Upside
Reiterated
03/31/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Deutsche Bank  Analyst forecast on DE:SHL
Deutsche Bank
Deutsche Bank
€46€42
Hold
16.70%
Upside
Reiterated
03/27/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (NASDAQ: MGTX), Hims & Hers Health (NYSE: HIMS) and Siemens Healthineers AG (Other OTC: SEMHF)
Barclays
€59€55
Buy
52.82%
Upside
Reiterated
03/25/26
Barclays Remains a Buy on Siemens Healthineers AG (SEMHF)
Jefferies Analyst forecast on DE:SHL
Jefferies
Jefferies
€60
Buy
66.71%
Upside
Reiterated
03/24/26
Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), Viatris (VTRS)
Bernstein
€52.15
Buy
44.90%
Upside
Reiterated
03/16/26
Analysts Offer Insights on Healthcare Companies: Cipher Pharmaceuticals (Other OTC: CPHRF) and Siemens Healthineers AG (Other OTC: SEMHF)
J.P. Morgan Analyst forecast on DE:SHL
J.P. Morgan
J.P. Morgan
€61.3
Buy
70.33%
Upside
Reiterated
03/13/26
J.P. Morgan Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
DZ BANK AG Analyst forecast on DE:SHL
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
03/09/26
DZ BANK AG Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)
DBS
€52
Buy
44.48%
Upside
Reiterated
02/24/26
DBS Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)
Citi
€60€59
Buy
63.93%
Upside
Reiterated
02/10/26
Siemens Healthineers price target lowered to EUR 59 from EUR 60 at CitiSiemens Healthineers price target lowered to EUR 59 from EUR 60 at Citi
Berenberg Bank Analyst forecast on DE:SHL
Berenberg Bank
Berenberg Bank
€54
Buy
50.04%
Upside
Reiterated
02/05/26
Berenberg Bank Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
Morgan Stanley Analyst forecast on DE:SHL
Morgan Stanley
Morgan Stanley
€48€45
Hold
25.03%
Upside
Reiterated
12/15/25
Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan StanleySiemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley
Exane BNP Paribas Analyst forecast on DE:SHL
Unknown Analyst
Exane BNP Paribas
Not Ranked
Exane BNP Paribas
€48
Hold
33.37%
Upside
Downgraded
12/10/25
Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas
Kepler Capital  Analyst forecast on DE:SHL
Kepler Capital
Kepler Capital
€59
Buy
63.93%
Upside
Reiterated
11/13/25
Kepler Capital Remains a Buy on Siemens Healthineers AG (SEMHF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

3 Months
xxx
Success Rate
13/33 ratings generated profit
39%
Average Return
-0.76%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 39.39% of your transactions generating a profit, with an average return of -0.76% per trade.
1 Year
Success Rate
11/33 ratings generated profit
33%
Average Return
-2.21%
Copying Hassan Al-Wakeel's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -2.21% per trade.
2 Years
xxx
Success Rate
20/57 ratings generated profit
35%
Average Return
-8.04%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.09% of your transactions generating a profit, with an average return of -8.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHL Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
2
2
Buy
24
24
21
22
17
Hold
6
8
9
7
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
32
30
31
25
In the current month, SHL has received 19 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. SHL average Analyst price target in the past 3 months is 53.42.
Each month's total comprises the sum of three months' worth of ratings.

SHL Financial Forecast

SHL Earnings Forecast

Next quarter’s earnings estimate for SHL is €0.51 with a range of €0.47 to €0.53. The previous quarter’s EPS was €0.49. SHL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.
Next quarter’s earnings estimate for SHL is €0.51 with a range of €0.47 to €0.53. The previous quarter’s EPS was €0.49. SHL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Sales Forecast

Next quarter’s sales forecast for SHL is €5.95B with a range of €5.66B to €7.11B. The previous quarter’s sales results were €5.40B. SHL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.
Next quarter’s sales forecast for SHL is €5.95B with a range of €5.66B to €7.11B. The previous quarter’s sales results were €5.40B. SHL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SHL has Performed in-line its overall industry.

SHL Stock Forecast FAQ

What is DE:SHL’s average 12-month price target, according to analysts?
Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is 53.42.
    What is DE:SHL’s upside potential, based on the analysts’ average price target?
    Siemens Healthineers AG has 48.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Siemens Healthineers AG a Buy, Sell or Hold?
          Siemens Healthineers AG has a consensus rating of Strong Buy, which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Siemens Healthineers AG’s share price target?
            The average share price target for Siemens Healthineers AG is 53.42. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €61.16 ,and the lowest forecast is €41.91. The average share price target represents 48.44% Increase from the current price of €35.99.
              What do analysts say about Siemens Healthineers AG?
              Siemens Healthineers AG’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Siemens Healthineers AG?
                To buy shares of DE:SHL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.